Churchill Capital XIII

Note 1 and the audited balance sheet establish the definitive post-IPO liquidity baseline that governs redemption calculus: the Trust Account contains exactly $414,000,000, setting the aggregate pool from which public shareholders will receive pro rata distributions if they elect to redeem or if the Company liquidates uncombined. The documented Combination Period timeframe creates the contractual window within which management must identify and close a target, triggering shareholder approval rights where investors may seek cash equal to their pro rata Trust Account share two business days prior to consummation. Note 2 management commentary indicates operating costs and due diligence will be funded exclusively from the $767,080 in external cash and potential Working Capital Loans, preserving the Trust principal pending a business combination, though Note 1 permits annual withdrawals up to $1,000,000 for administrative expenses or taxes. Sponsor incentives are structurally locked: the $30,000 monthly administrative fee and the $16,990,000 deferred underwriting obligation accelerate payout timelines, particularly given that $1,500,000 becomes payable immediately upon announcing a definitive agreement. Note 8 provides fair value assumptions for Public Warrants (10.4% volatility, 4.30% risk-free rate, 2.69-year weighted term, 14.3% market pricing adjustment) that will influence derivative pricing until deal terms are fixed. Because the Company remains in a pre-operation phase per Note 1, no revenue targets, customer claims, or sector strategies are disclosed, making this filing purely a structural and accounting anchor for all future extension votes, redemption elections, and business combination proxy statements.

This filing establishes the trust value per share at $10.00 and confirms the 24-month deadline (August 2028) for the SPAC to complete a deal. It provides the contractual framework for redemptions, warrant exercise, and sponsor alignment. Investors can now track the trust balance and timeline. No business combination target has been identified.

Churchill XIII may extend from 24 months to 27 months if a letter of intent, agreement in principle or definitive agreement is executed within 24 months of closing, and the prospectus states that no redemption rights are offered to public shareholders in connection with that extension, so holders cannot exit at the three-month step. Deferred underwriting totals $15,100,000 ($16,990,000 with full over-allotment): $12,600,000 held in trust, $1,500,000 payable from funds outside trust on announcement of a definitive agreement, and $1,000,000 at consummation.

The filing establishes a $10.00 trust per share with a 24-month deadline (27 months if a definitive agreement is signed within 24 months). Michael Klein's sponsor group pays $0.002/share for founder shares (11.5M shares) and $10.00/unit for 350,000 private placement units — creating the standard SPAC incentive misalignment where sponsor can profit even if public shareholders lose value. The filing discloses that Mr. Klein and the same management team operate multiple concurrent SPACs (CCXI with a pending Agility Robotics deal, CXII searching, CCIX recently liquidating), creating explicit conflicts of interest in allocating deal opportunities. The underwriter is Citigroup.

What changed: Form 8-K Current Report and accompanying Exhibit 99.1 documenting the consummation of Churchill Capital Corp XIII’s Initial Public Offering and concurrent private placement on August 3, 2026. Per Item 8.01 and Note 1, the Company states it consummated its Initial Public Offering on August 3, 2026, selling 41,400,000 Units at $10.00 per Unit for $414,000,000 in gross proceeds, fully exercising a 5,400,000-unit over-allotment option. Note 3 and Note 4 confirm the simultaneous private sale of 350,000 Private Placement Units to Sponsor Churchill Sponsor XIII LLC at $10.00 per unit for $3,500,000. The filing specifies that $414,000,000 was deposited into a U.S.-based Trust Account maintained by Continental Stock Transfer & Trust Company, comprising $412,500,000 in net IPO proceeds (which includes up to $15,490,000 of the underwriter’s deferred discount) and $1,500,000 from the Private Placement. Note 1 establishes the Combination Period as 24 months from the closing of the Initial Public Offering, extending to 27 months if a letter of intent, agreement in principle, or definitive agreement is executed within the first 24 months. The audited balance sheet and Note 7 record 41,400,000 Class A ordinary shares subject to possible redemption at a stated value of $10.00 per share, with each whole warrant entitling holders to purchase shares at $11.50 per share exercisable 30 days after a business combination. Note 5 discloses the Sponsor holds 13,800,000 Founder Shares following the full over-allotment exercise and outlines a $30,000 monthly administrative services reimbursement to the Sponsor’s managing member. Note 6 details $16,990,000 in deferred underwriting discounts, allocating $15,490,000 to the Trust Account payable solely upon a completed business combination and $1,500,000 to funds outside the Trust Account payable upon announcing a definitive agreement. Exhibit 99.1, audited by WithumSmith+Brown, PC, presents $414,000,000 in Cash held in Trust Account, $767,080 in unrestricted cash, total current liabilities of $143,811, and a total shareholders’ deficit of $(15,668,309). Why it matters: Note 1 and the audited balance sheet establish the definitive post-IPO liquidity baseline that governs redemption calculus: the Trust Account contains exactly $414,000,000, setting the aggregate pool from which public shareholders will receive pro rata distributions if they elect to redeem or if the Company liquidates uncombined. The documented Combination Period timeframe creates the contractual window within which management must identify and close a target, triggering shareholder approval rights where investors may seek cash equal to their pro rata Trust Account share two business days prior to consummation. Note 2 management commentary indicates operating costs and due diligence will be funded exclusively from the $767,080 in external cash and potential Working Capital Loans, preserving the Trust principal pending a business combination, though Note 1 permits annual withdrawals up to $1,000,000 for administrative expenses or taxes. Sponsor incentives are structurally locked: the $30,000 monthly administrative fee and the $16,990,000 deferred underwriting obligation accelerate payout timelines, particularly given that $1,500,000 becomes payable immediately upon announcing a definitive agreement. Note 8 provides fair value assumptions for Public Warrants (10.4% volatility, 4.30% risk-free rate, 2.69-year weighted term, 14.3% market pricing adjustment) that will influence derivative pricing until deal terms are fixed. Because the Company remains in a pre-operation phase per Note 1, no revenue targets, customer claims, or sector strategies are disclosed, making this filing purely a structural and accounting anchor for all future extension votes, redemption elections, and business combination proxy statements.

What changed: A Schedule 13G joint filing agreement (routine compliance exhibit) confirming that Integrated Core Strategies (US) LLC, Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander will submit a single beneficial ownership report for Class A Ordinary Shares (par value $0.0001 per share) of Churchill Capital Corp XIII under Rule 13d-1(k). Mechanics: This filing reports no changes to redemption deadlines, trust account valuations, extension motions, deal pipeline status, or sponsor governance. Substance: Beyond the administrative consolidation of reporting obligations under Rule 13d-1(k), the document contains zero claims regarding customers, revenue streams, total addressable market, strategic pivots, intellectual property, channel partnerships, active litigation, or key personnel movements. The only assertions are the procedural confirmations signed by Global General Counsel Gil Raviv and founder Israel A. Englander on August 6, 2026. Why it matters: The bundled filing confirms unified institutional reporting structure for Millennium’s interests but delivers no actionable intelligence on Churchill Capital XIII’s SEARCHING phase or its 2028-07-31 mandatory liquidation timeline. Because it discloses neither ownership thresholds, acquisition targets, nor sponsor amendments, it holds no immediate impact on the redemption calendar, trust value preservation, or deal momentum, representing a standard regulatory formality rather than a material catalyst.

What changed: Routine compliance exhibit: a Joint Filing Agreement attached to a Schedule 13D beneficial ownership report, executed on August 7, 2026, by Churchill Sponsor XIII LLC, Michael Klein, and M. Klein Associates, Inc. No changes to redemption mechanics, trust value, extensions, or deal progress are introduced. As represented by Churchill Sponsor XIII LLC, Michael Klein, and M. Klein Associates, Inc., each party accepts responsibility for the timeliness and accuracy of its own Schedule 13D disclosures and acknowledges awareness of any inaccuracies regarding the other filers. The document contains no substantive claims about customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel. Why it matters: For investors tracking the SPAC’s operational calendar, this filing preserves the searching status, the July 31, 2028 termination date, and the external tracking figure of $10 per share in the trust account. Because the agreement only coordinates administrative filing responsibilities among current reporting persons, it alters neither shareholder redemption windows, trust distribution mechanics, nor sponsor governance conduct. Nothing in the text recomputes valuations, modifies contractual deadlines, or impacts trust account administration.

What changed: Form 4 — insider ownership report filed by Churchill Capital Corp XIII. According to the Form 4 filing, on 2026-08-03, reporting person Michael Stuart Klein (identified in the filing as a director and 10% owner), along with M. Klein Associates, Inc. (also identified as a 10% owner) and CHURCHILL SPONSOR XIII LLC (also identified as a 10% owner), executed an open-market purchase of 350,000 shares at $10. The filing states the reporting persons own 350,000 shares after the transaction. The document makes no claims regarding adjustments to the trust account value, redemption mechanics, extension votes, timeline deadlines, or business combination status. Why it matters: Per the filing, the disclosed activity reflects secondary market accumulation by named insiders rather than trust distribution or merger execution. The filing attributes the $10 purchase price directly to the open market and notes no change to public shareholder liquidity conditions. The submission contains no claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel movements beyond the reported director title and 10% ownership designation. Consequently, the filing serves as a routine regulatory update that does not alter the SPAC’s redemption calendar or trust mechanics.

What changed: Joint Filing Agreement (Exhibit 99.1) attached to a Schedule 13G beneficial ownership report, constituting a routine compliance exhibit for continuing SEC disclosure obligations. The execution of the agreement alters no redemption deadlines, trust account valuations, extension timelines, merger advancement stages, or sponsor conduct protocols. The document records that MMCAP International Inc. SPC and MM Asset Management Inc. will file future 13G amendments jointly, with Ulla Vestergaard acting as Director for the former and Hillel Meltz acting as President for the latter. Why it matters: According to Exhibit 99.1, each signatory retains independent liability for the accuracy and completeness of its own reported information, while accepting secondary responsibility for the other’s disclosures only 'to the extent that he or it knows or has reason to believe that such information is inaccurate.' This provision strictly governs administrative filing logistics for ongoing equity tracking and does not introduce business combination targets, target company financials, market sizing claims, technology roadmaps, partnership arrangements, litigation developments, or personnel transitions beyond the two named executives. Investors monitoring Churchill Capital XIII’s operational trajectory or trust mechanics will find no actionable updates beyond standard regulatory housekeeping.